Since its inception eight years ago, Apollo Radiology International has emerged as a preferred radiology partner for hospitals and imaging centers worldwide. Today, Apollo Radiology International is present in 32 countries, operating advanced reporting hubs in India, the UK, and the USA, and serving more than 150 healthcare providers through a team of around 200 radiologists. Beyond radiology reporting services, Apollo Radiology International has also established itself as a leader in radiology education through ARI Academy, which has been training radiologists globally across subspecialties. With delegates from 18 countries and an alumni base of more than 2,000 radiologists, the Academy brings together faculty from the USA, UK, UAE, and India. ARI Academy has also partnered with the Royal College of Radiologists (RCR) to conduct FRCR exams. Further strengthening its innovation footprint, Apollo Radiology International has partnered with Google to leverage advanced AI algorithms for the early detection of tuberculosis and lung cancer, enabling these solutions to be deployed in remote hospital settings across India. This integration of global clinical expertise, education, and cutting-edge AI positions Apollo Radiology International as a unique and comprehensive leader in transforming radiology services worldwide.
ANT BIO PTE. LTD.
AntBio specializes in the research and development of recombinant antibodies and proteins, as well as various assay reagents for basic research, drug development, cell therapy, gene therapy, and in vitro diagnostics. Our product portfolio includes high-quality antibodies, target proteins, cytokines, enzymes, and assay kits, aiming to provide high-quality products and professional services to customers in the life sciences.
Anivance AI
Anivance AI stands at the forefront of intelligent healthcare innovation, specializing in human organ model solutions. A decade of experience with respiratory models has driven us to achieve significant advancements in preclinical testing and earned us the prestigious 2023 Moderna Taiwan mRNA Innovation Award. This recognition is a testament to our unwavering commitment to improving healthcare and reflects our mission: Saving Lives: Now a Reality. Our comprehensive services, designed to accelerate the drug discovery and safety assessment processes, leverage human-simulated data to bridge the gap between laboratory findings and clinical applications. By precisely simulating human responses, we provide the pharmaceutical industry with powerful tools for thorough safety and efficacy evaluation. | Anivance AI is bridging Taiwan’s world-class semiconductor and manufacturing expertise with AI and life sciences, creating a new era of intelligent drug discovery. By integrating AI-powered organ-on-chip technology with automated high-throughput research, we provide pharmaceutical companies with a scalable, self-optimizing platform that accelerates preclinical testing and delivers breakthrough insights. Unlike traditional preclinical models, our platform is continuously learning and adapting, optimizing experiment design, mechanistic analysis (MOA), and real-time data interpretation. By embedding AI agents into automated research workflows, we help pharmaceutical companies make faster, smarter, and more data-driven decisions, significantly reducing preclinical failure rates and improving R&D efficiency. With 25 granted and pending patents, Anivance AI collaborates with leading global pharmaceutical companies and six clinical institutions, ensuring that our technology is aligned with real-world drug development needs. We have validated our high-throughput organ-on-chip platform in lung, liver, and oncology models, with expanding applications in autoimmune diseases and cardiovascular research. Our breakthroughs in inhalable nanoparticle delivery and respiratory disease modeling have earned global recognition, including a nomination for the LUSH Prize in Science. By leveraging Taiwan’s semiconductor supply chain and precision manufacturing ecosystem, we deliver a new level of automation, AI-driven analytics, and experimental scalability that was previously unattainable in biotech. Backed by two of Taiwan’s largest publicly traded companies and validated by over 50 collaborating physicians, Anivance AI is one of Taiwan’s fastest-growing biotech startups, now expanding into the global market. We are not just developing technology—we are reshaping the future of AI-powered drug discovery. With a foundation built on semiconductor precision, AI intelligence, and biotech innovation, Anivance AI provides pharmaceutical companies with the tools to make transformative breakthroughs, faster than ever before. | Anivance AI is a deep tech company developing Physical AI infrastructure for decision-grade human biology in early drug development and translational research. Rather than operating as a service provider or a single model technology, Anivance AI is designed as an integrated system. Physical organ models function as the sensing layer. Standardized execution and biological baselines form the control layer. Structured data intelligence provides the reasoning layer. Together, these components support closed loop experimentation and decision making. We integrate three tightly coupled layers into a single Physical AI platform. 1. Engineering grade physical organ systems Hard structured organ on chip and microphysiological systems designed for long term stability and reproducible operation under dynamic physiological conditions. The systems support continuous microfluidic circulation, vascular side dosing, dynamic exposure workflows including inhalation relevant conditions, and long duration experiments. 2. Standardized biological baselines and profiles Reusable organ and disease profiles that define execution and interpretation standards, reduce variability across batches and operators, and enable cross study comparability. 3. Human data foundry and decision loop Integrated imaging, functional readouts, and structured experimental metadata form a continuously accumulating human data infrastructure. This supports AI assisted analysis, iterative model refinement, and decision oriented reporting aligned with regulatory expectations. The platform has been deployed across lung and inhalation, liver, kidney, CNS and BBB, oncology, and rare disease applications, supporting more than 25 experimental programs across North America, Japan, South Korea, and Europe. | Anivance AI Corporation is a tech startup integrating miniaturized human organ systems on chips with Multi-Agent AI to accelerate drug discovery. Backed by 35 patents and thousands of data points across multiple organ and disease models, Anivance AI advances 20+ projects and expands across North America, Japan, South Korea, and Europe.
Andelyn Biosciences
Our Vision: Pioneering Solutions that turn Hope into Reality Our Mission: Accelerating the development and manufacturing of innovative therapies to bring more treatments to more patients Andelyn Biosciences (https://www.andelynbio.com/) is pioneering solutions that turn hope into reality as a cell and gene therapy CDMO. Capabilities span viral vector process and analytical development, small to large scale adherent and suspension based GMP manufacturing up to 2000L. Having 20+ years of experience with viral vector manufacturing, Andelyn offers access to globally recognized thought leaders with troubleshooting/characterization expertise and GMP material produced for 75+ worldwide clinical trials. In addition to producing 400+ cGMP clinical batches, Andelyn provides research and tox grade plasmids with an additional offering of GMP plasmid manufacturing, full quality system/regulatory support and supply chain vertical integration. Its state-of-the-art 185,000 sq ft commercial manufacturing facility will expand capacity across 8+ production suites for customization of new programs and tech transferred programs, offering clinical through commercial-scale capabilities that will help accelerate innovative therapies to bring more treatments to more patients. Gene and cell therapy, AAV viral vector manufacturing, Plasmid Manufacturing, Lentiviral vector Manufacturing, Commercial Manufacturing, CDMO, analytical method development, GMP, fill finish, QC/QA release testing, Process Characterization, Regulatory Affairs, Licensing Andelyn Biosciences is a pioneering cell and gene therapy organization born out of Nationwide Children’s Hospital, where the first FDA-approved systemic gene therapy was discovered. See all our Press Releases at: https://www.andelynbio.com/media-center | Andelyn Biosciences (https://www.andelynbio.com/) is pioneering solutions for Turning Hope into Reality (TM) as a gene therapy CDMO. Capabilities span viral vector process and analytical development, small to large scale adherent and suspension based GMP manufacturing up to 2000L. With 20+ years of experience in viral vector manufacturing, Andelyn offers access to globally recognized thought leaders with troubleshooting and characterization expertise and GMP material produced for 75+ worldwide clinical trials. In addition to producing 450+ cGMP sublots, Andelyn provides research, tox, and GMP grade plasmids Andelyn also has full quality and regulatory support and supply chain vertical integration. Its state-of-the-art 185,000 sq ft commercial manufacturing facility offers capacity across 16 production suites for customization of new programs as well as tech transfer programs, offering clinical through commercial-scale capabilities that will help accelerate innovative therapies to bring more treatments to more patients. Andelyn Biosciences is a pioneering gene therapy CDMO born out of Nationwide Children’s Hospital, where the first FDA-approved systemic gene therapy was discovered. | Andelyn Biosciences is a full-service cell and gene therapy CDMO focused on the development, characterization and production of viral vectors for gene therapy. With more than 20 years of experience, Andelyn’s deep scientific expertise has resulted in the production of cGMP material for more than 450 clinical batches and 75 global clinical trials. Operating out of its development and manufacturing facilities in Columbus, Ohio, Andelyn supports its clients in developing cell and gene therapies from concept through plasmid engineering and manufacturing, process and analytical development, and cGMP clinical and commercial manufacturing. Andelyn can accelerate programs and deliver high quality products by developing and manufacturing processes on its configurable, data-driven AAV CuratorTM Platform, or tech transferring in an established client program. Capabilities include cGMP manufacturing for suspension processes up to a 2,000-liter and adherent processes. A rigorous quality system, regulatory support, and supply chain vertical integration further support clients in bringing their critical therapies to market. For more information, visit andelynbio.com. For Andelyn media inquiries, please contact: media@andelynbiosciences.com
Amrad Medical/Summit Industries, LLC
Summit Industries, LLC is a leading x-ray supplier and manufacturer of high-quality digital X-ray systems designed for high-volume procedures in focused specialties. Summit’s premiere medical brand, AMRAD Medical, includes a diverse portfolio of conventional and specialty imaging systems that can be found in hospitals, diagnostic imaging centers, orthopedic surgeon offices, urgent care facilities, and physician clinics across the globe. The AMRAD Medical product line includes general radiographic systems as well as R/F systems, surgical C-arm systems, single detector solutions, portable and mobile imaging systems with DR upgrade package options. Each AMRAD Medical system can be configured to create the right system for your specific needs. All configurations offer a choice of high-performance imaging components, x-ray tubes, and generators for tailored solutions. Visit our booth and meet the Summit team to learn about the AMRAD Medical product line.
AMI Polymer
Since 1998, Ami Polymer Pvt Ltd is in the business of Silicone Elastomeric products and other Polymeric components. We provide solutions to Fluid Transfers, Sealing and Contamination controls for Biopharma, Pharma, Medical, Laboratory, Food & Beverages and Engineering sectors worldwide. We have ISO Class 7 and ISO Class 8 Cleanroom facilities certified with ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 27001:2013, ISO 13485:2016. We also have a Toxikon, USA & BPOG Leachable & Extractable studies for our products for regulatory markets worldwide. The biopharmaceutical industry is increasingly moving towards the use of single-use disposable systems for the development and manufacturing of a wide range of therapeutic proteins, Mabs, and vaccines. APPL offers a wide range of gamma-irradiated single-use assemblies for various critical applications in biopharmaceuticals. Our products range from simple tubing with connectors to a complex manifold with several joints and connections. All the assemblies are manufactured and packed in an ISO Class 7-certified clean room. Most of the key components used in our single-use assemblies are manufactured in-house. Ami Polymer delivers multiple tubing options made of thermoplastic elastomers as well as platinum-cured silicone. These are offered in a wide range of internal and outer diameters to meet the process requirements with respect to fitment into peristaltic pumps and different size connections We offer single use product as 2D and 3D bags, Mixing and Sampling bags, sanitary tri-clamp, quick connectors, PP connectors, over molded assemblies, bellows, inflatable seals. | Since 1998, APPL is in the business of Silicone Elastomeric products and also, other Polymeric components which ultimately provide solutions to Fluid Transfers, Sealing, and Contamination controls for Biopharma, Pharma, Medical, Laboratory, Food, Beverages, and Engineering sectors worldwide. APPL is having ISO Class VII and ISO Class VIII Cleanroom facilities certified with ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 27001:2013, ISO 13485:2016. We also have a BPOG extractables program for our products for regulatory markets worldwide. The company believes in “Be in business with ethics” and assure Quick Development, Fastest Delivery, Ultimate Quality and also very Competitive Rates. APPL has world-class manufacturing technology with end-to-end process capabilities to fulfill the needs of customers. which include Extrusion Technology with Laser Controlled system, Automatic Hose Production lines, Plastic Extrusion Lines, Automatic Hydraulic Presses for Elastomers & Polymeric components, Laboratory with R&D Equipment, In-house Tooling & Mould making machinery, Laser Cut Machines, and Online Printing as well as Marking systems on products. Over the years the Company expanded its capacity of manufacturing by adding a huge facility that provides end-to-end solutions to our clients worldwide. Our products are available across the globe directly and through the distribution networks. Product that we are offering 1. Single Use Bag ( 2D, 3D & Tank Liner ) 2. Single Use Assembly Along With Filters 3. Pump Grade Tubing 4. High Pressure Hose 5. Overmolded Assemblies 6. Tri-Clover Gaskets, O-rings, Extruded Profile | Ami Polymer is one of India’s leading manufacturers of high‑performance silicone elastomeric and advanced polymer components, serving regulated industries across the globe. The company was founded in 1998 and has since grown into a trusted partner for world‑class organizations in Biopharma, Pharmaceuticals, Medical Devices, Laboratory, Food & Beverage, and Engineering sectors.